Gundersen Lutheran Medical Foundation Internal Medicine

Topics

• Pancreatic and Hepatic Oncology Research 50
• Gastrointestinal Tumor Research and Treatment 45
• Glaucoma and retinal disorders 43
• Colorectal Cancer Treatments and Studies 36
• Cerebral Venous Sinus Thrombosis 28
• Cancer Immunotherapy and Biomarkers 23
• Endometrial and Cervical Cancer Treatments 23
• Lymphoma Diagnosis and Treatment 21
• Multiple Sclerosis Research Studies 17
• Cancer Genomics and Diagnostics 14
• Global Cancer Incidence and Screening 14
• Sympathectomy and Hyperhidrosis Treatments 14

Most cited

1. Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint Inhibitors.

   Frontiers in immunology · 2022 · 291 citations · Adithya Chennamadhavuni

2. Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 195 citations · Shivani Kapur

3. Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study.

   The Lancet. Oncology · 2021 · 345 citations · Ben George

4. Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 265 citations · Charles Blanke

5. Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 38 citations · Rasmus Hoeg

6. CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy.

   Nature medicine · 2026 · 16 citations · Shivani Kapur

7. ALK fusions in the pan-cancer setting: another tumor-agnostic target?

   NPJ precision oncology · 2023 · 97 citations · Ben George

8. Optical Coherence Tomography Neuro-Toolbox for the Diagnosis and Management of Papilledema, Optic Disc Edema, and Pseudopapilledema.

   Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society · 2021 · 69 citations · Randy Kardon